FDA Adverse Event Injury Summary report: N

TOTAL HIP BALL 32MM +11

MDR report key: 3233557 · Received July 18, 2013

Report

Report Number
1818910-2013-21564
Event Type
Injury
Date Received
July 18, 2013
Date of Event
July 9, 2013
Report Date
July 9, 2013
Manufacturer
1818910 DEPUY ORTHOPAEDICS, INC.
Product Code
JDI
PMA / PMN Number
PK860701
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
IN, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

IF INFORMATION IS OBTAINED THAT WAS NOT AVAILABLE FOR THE INITIAL MEDWATCH, A FOLLOW-UP MEDWATCH WILL BE FILED AS APPROPRIATE. PATIENT WAS REVISED TO ADDRESS DISLOCATION. THE REPORT STATES THAT THE PATIENT IS MOST LIKELY NON-COMPLIANT. DOI (B)(6) 2003 - DOR (B)(6) 2013 (RIGHT HIP). THE DEVICES ASSOCIATED WITH THIS REPORT WERE NOT RETURNED. A COMPLAINT DATABASE SEARCH FINDS NO OTHER REPORTED INCIDENTS AGAINST THE PROVIDED PRODUCT AND LOT COMBINATIONS SINCE THEIR RELEASE FOR DISTRIBUTION. REQUESTS FOR ADDITIONAL INVESTIGATIONAL INPUTS WERE MADE IN ACCORDANCE WITH WI-7915 APPENDIX A. MEDICAL RECORDS WERE OBTAINED. THEY ARE 2003 PRIMARY SURGICAL NOTES AND DO NOT OFFER ANY INFORMATION REGARDING THIS REVISION. THE INVESTIGATION COULD NOT DRAW ANY CONCLUSIONS REGARDING THE REPORTED EVENT. BASED ON THE INABILITY TO DETERMINE A ROOT CAUSE, THE NEED FOR CORRECTIVE ACTION WAS NOT INDICATED. DEPUY CONSIDERS THE INVESTIGATION CLOSED. SHOULD ADDITIONAL INFORMATION BE RECEIVED, THE INFORMATION WILL BE REVIEWED AND THE INVESTIGATION WILL BE RE-OPENED AS NECESSARY.

Additional Manufacturer Narrative · 1

THIS COMPLAINT IS STILL UNDER INVESTIGATION. DEPUY WILL NOTIFY THE FDA OF THE RESULTS OF THIS INVESTIGATION ONCE IT HAS BEEN COMPLETED.

Description of Event or Problem · 1

PATIENT WAS REVISED TO ADDRESS DISLOCATION. THE REPORT STATES THAT THE PATIENT IS MOST LIKELY NON-COMPLIANT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
333837 TOTAL HIP BALL 32MM +11 FEMORAL HEAD JDI 1818910 DEPUY ORTHOPAEDICS, INC. V68GC1016

Patients

Seq Age Sex Outcome Treatment
1 74 YR Required Intervention